Corbus Pharmaceuticals Advances Oncology Research with First Patient Dosed in CRB-601 Clinical Trial for Advanced Solid Tumors
Corbus Pharmaceuticals begins Phase 1 trial for CRB-601, a monoclonal antibody targeting advanced solid tumors.Quiver AI SummaryCorbus Pharmaceuticals Holdings, Inc. recently announced the dosing of the...
2 'Strong Buy' Biotech Stocks With 120% or More Upside Potential
With the growing demand for cutting-edge therapies reshaping the healthcare landscape, here are two “Strong Buy”-rated biotech stocks with significant potential upside.
Corbus Pharmaceuticals Receives FDA Fast Track Designation for CRB-701 in Treating Metastatic Cervical Cancer
Corbus Pharmaceuticals announced FDA Fast Track designation for CRB-701, targeting metastatic cervical cancer with a Phase 1 trial ongoing.Quiver AI SummaryCorbus Pharmaceuticals Holdings, Inc. announced...
Corbus Pharmaceuticals: Q3 Earnings Snapshot
Corbus Pharmaceuticals: Q3 Earnings Snapshot